Kausar J. Jabbar - Concepedia

Author

Kausar J. Jabbar

The University of Texas MD Anderson Cancer Center

Also Known As

K J Jabbar, K Jabbar, K. J. Jabbar, Kashaf Jabbar, Kausar J. Jabbar, Kausar Jabbar, Kausar Jabeen Jabbar, Winter, Jane N.

Publications

839

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Radboud University Medical Center Radboud University Nijmegen NewYork–Presbyterian Hospital Cornell University

About

Kausar J. Jabbar is an author at The University of Texas MD Anderson Cancer Center specializing in pathology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	371
2	Pathology	7	7	371
3	Immunology	6	6	355
4	Cell Biology	1	1	59
5	Orthopaedics	1	1	110

Kausar J. Jabbar

Publications

805

Citations

H-Index

Page 1

	Year	Citations
Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene Narine Hakobyan, Tamara Kazarian, Adnan Abdul Jabbar, Blood	2004	149
Experimental haemophilic synovitis: rationale and development of a murine model of human factor VIII deficiency Leonard A. Valentino, N. HAKOBYAN, Tamara Kazarian, Haemophilia ImmunologyPathologyImmune SystemOrthopaedic SurgeryInflammation	2004	110
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma Zijun Y. Xu‐Monette, Ling Li, John C. Byrd, Blood	2016	107
Clinical and biological significance of<i>de novo</i>CD5+ diffuse large B-cell lymphoma in Western countries Zijun Y. Xu‐Monette, Meifeng Tu, Kausar J. Jabbar, Oncotarget Hematological MalignancyTumor BiologyDlbcl PatientsLymphoid NeoplasiaWestern Countries	2015	87
Hotspot Mutation Panel Testing Reveals Clonal Evolution in a Study of 265 Paired Primary and Metastatic Tumors Rashmi S. Goswami, Keyur P. Patel, Rajesh R. Singh, Clinical Cancer Research	2015	75
Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma Xiaoxiao Wang, Xin Cao, Ruifang Sun, Neoplasia	2018	64
Tetraspanin CD37 protects against the development of B cell lymphoma Charlotte M. de Winde, Sharon Veenbergen, Ken H. Young, Journal of Clinical Investigation Lymphoid NeoplasiaLymphocyte DevelopmentLymphoma DevelopmentMalignant Blood DisorderImmunology	2016	59
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma Jinfen Wang, Zijun Y. Xu‐Monette, Kausar J. Jabbar, American Journal Of Pathology Hematological MalignancyLymphoid NeoplasiaMedicineMalignant Blood DisorderImmunology	2017	57
An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes May Daher, Juliana Elisa Hidalgo Lopez, Jasleen K. Randhawa, American Journal of Hematology	2017	27
Comparison of Next-generation Sequencing Mutation Profiling With BRAF and IDH1 Mutation-specific Immunohistochemistry Kausar J. Jabbar, Rajalakshmi Luthra, Keyur P. Patel, The American Journal of Surgical Pathology GeneticsImmunologyPathologyDisease Gene IdentificationGenomics	2015	25

Page 1